172 related articles for article (PubMed ID: 10642646)
1. [Treatment of intimal hyperplasia by gene therapy: an update].
Reis E; Martinet O; Mosimann F
J Mal Vasc; 1999 Dec; 24(5):349-55. PubMed ID: 10642646
[TBL] [Abstract][Full Text] [Related]
2. Update on gene therapy for intimal hyperplasia.
Reis ED; Skladany M
Bratisl Lek Listy; 1999 Aug; 100(8):417-21. PubMed ID: 10645028
[TBL] [Abstract][Full Text] [Related]
3. The paradigm of restenosis following percutaneous transluminal coronary angioplasty.
Preisack MB; Karsch KR
Eur Heart J; 1993 Nov; 14 Suppl I():187-92. PubMed ID: 8293774
[TBL] [Abstract][Full Text] [Related]
4. [Gene therapy of restenosis].
Steg PG; Feldman L
Pathol Biol (Paris); 1998 Mar; 46(3):201-4. PubMed ID: 9769916
[TBL] [Abstract][Full Text] [Related]
5. The vessel wall reaction in restenosis.
Schwartz RS
Semin Interv Cardiol; 1997 Jun; 2(2):83-8. PubMed ID: 9546996
[TBL] [Abstract][Full Text] [Related]
6. Dominant negative c-jun gene transfer inhibits vascular smooth muscle cell proliferation and neointimal hyperplasia in rats.
Yasumoto H; Kim S; Zhan Y; Miyazaki H; Hoshiga M; Kaneda Y; Morishita R; Iwao H
Gene Ther; 2001 Nov; 8(22):1682-9. PubMed ID: 11892835
[TBL] [Abstract][Full Text] [Related]
7. Molecular strategy using cis-element 'decoy' of E2F binding site inhibits neointimal formation in porcine balloon-injured coronary artery model.
Nakamura T; Morishita R; Asai T; Tsuboniwa N; Aoki M; Sakonjo H; Yamasaki K; Hashiya N; Kaneda Y; Ogihara T
Gene Ther; 2002 Apr; 9(8):488-94. PubMed ID: 11948373
[TBL] [Abstract][Full Text] [Related]
8. Effect of gene delivery of NOS isoforms on intimal hyperplasia and endothelial regeneration after balloon injury.
Cooney R; Hynes SO; Sharif F; Howard L; O'Brien T
Gene Ther; 2007 Mar; 14(5):396-404. PubMed ID: 17080182
[TBL] [Abstract][Full Text] [Related]
9. Myointimal hyperplasia: basic science and clinical considerations.
Neville RF; Sidawy AN
Semin Vasc Surg; 1998 Sep; 11(3):142-8. PubMed ID: 9763114
[TBL] [Abstract][Full Text] [Related]
10. Prevention of restenosis by a herpes simplex virus mutant capable of controlled long-term expression in vascular tissue in vivo.
Skelly CL; Curi MA; Meyerson SL; Woo DH; Hari D; Vosicky JE; Advani SJ; Mauceri HJ; Glagov S; Roizman B; Weichselbaum RR; Schwartz LB
Gene Ther; 2001 Dec; 8(24):1840-6. PubMed ID: 11821937
[TBL] [Abstract][Full Text] [Related]
11. Adenovirus-mediated arterial gene therapy for restenosis: problems and perspectives.
Feldman LJ; Tahlil O; Steg PG
Semin Interv Cardiol; 1996 Sep; 1(3):203-8. PubMed ID: 9552512
[TBL] [Abstract][Full Text] [Related]
12. Blockade of vascular smooth muscle cell proliferation and intimal thickening after balloon injury by the sulfated oligosaccharide PI-88: phosphomannopentaose sulfate directly binds FGF-2, blocks cellular signaling, and inhibits proliferation.
Francis DJ; Parish CR; McGarry M; Santiago FS; Lowe HC; Brown KJ; Bingley JA; Hayward IP; Cowden WB; Campbell JH; Campbell GR; Chesterman CN; Khachigian LM
Circ Res; 2003 May; 92(8):e70-7. PubMed ID: 12690039
[TBL] [Abstract][Full Text] [Related]
13. In vivo suppression of restenosis in balloon-injured rat carotid artery by adenovirus-mediated gene transfer of the cell surface-directed plasmin inhibitor ATF.BPTI.
Lamfers ML; Lardenoye JH; de Vries MR; Aalders MC; Engelse MA; Grimbergen JM; van Hinsbergh VW; Quax PH
Gene Ther; 2001 Apr; 8(7):534-41. PubMed ID: 11319620
[TBL] [Abstract][Full Text] [Related]
14. [Gene therapy for the treatment of restenosis after coronary angioplasty].
Rapacciuolo A; Indolfi C; Di Lorenzo E; Esposito G; Stabile E; Stingone AM; Avvedimento EV; Condorelli M; Chiariello M
Cardiologia; 1994 Dec; 39(12):843-7. PubMed ID: 7781002
[TBL] [Abstract][Full Text] [Related]
15. Gene inhibition and gene augmentation for the treatment of vascular proliferative disorders.
von der Leyen HE; Mann MJ; Dzau VJ
Semin Interv Cardiol; 1996 Sep; 1(3):209-14. PubMed ID: 9552513
[TBL] [Abstract][Full Text] [Related]
16. Post-intervention vessel remodeling.
Rutanen J; Puhakka H; Ylä-Herttuala S
Gene Ther; 2002 Nov; 9(22):1487-91. PubMed ID: 12407420
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms and prevention of restenosis: from experimental models to clinical practice.
Bauters C; Meurice T; Hamon M; McFadden E; Lablanche JM; Bertrand ME
Cardiovasc Res; 1996 Jun; 31(6):835-46. PubMed ID: 8759238
[No Abstract] [Full Text] [Related]
18. Potent inhibition of arterial intimal hyperplasia by TIMP1 gene transfer using AAV vectors.
Ramirez Correa GA; Zacchigna S; Arsic N; Zentilin L; Salvi A; Sinagra G; Giacca M
Mol Ther; 2004 Jun; 9(6):876-84. PubMed ID: 15194054
[TBL] [Abstract][Full Text] [Related]
19. Cryoplasty for the prevention of arterial restenosis.
Wildgruber MG; Berger HJ
Cardiovasc Intervent Radiol; 2008; 31(6):1050-8. PubMed ID: 18535858
[TBL] [Abstract][Full Text] [Related]
20. Local administration of NF-kappa B decoy oligonucleotides to prevent restenosis after balloon angioplasty: an experimental study in New Zealand white rabbits.
Kalinowski M; Viehofer K; Hamann C; Barry JJ; Kleb B; Klose KJ; Wagner HJ; Alfke H
Cardiovasc Intervent Radiol; 2005; 28(3):331-7. PubMed ID: 15886949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
